This inventor holds 3 USPTO granted patents and 6 published patent applications, plus 4 CIPO patents and 3 EPO patents. Top assignees: Enzo Therapeutics, Inc., Tel Aviv University, The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center. Active years: 2017-2020.
Company Filing History:
2 out of 31 
1 out of 841 
1 out of 60 
Years Active: 2017-2020
Title: Ari Zimran: Innovator in Medical Treatments
Introduction
Ari Zimran is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of medical treatments, particularly in the areas of immune-mediated diseases and lysosomal storage disorders. With a total of 3 patents to his name, Zimran's work is paving the way for innovative therapeutic solutions.
Latest Patents
Zimran's latest patents include a method for the treatment of immune-mediated or immune-related diseases, infectious diseases, metabolic disorders, and cancer in mammalian subjects. This method involves the administration of a naturally occurring, mammalian intermediary metabolite or T cell receptor ligand, preferably a glucosylceramide, to a mammalian subject, with a focus on human beings. Another significant patent relates to enzyme replacement therapy for treating lysosomal storage diseases. This invention encompasses chimeric proteins, including protein hormone-therapeutic protein conjugates and fusion proteins, designed to cross the blood-brain barrier for effective treatment.
Career Highlights
Throughout his career, Ari Zimran has worked with prominent organizations such as Enzo Therapeutics, Inc. and Tel Aviv University. His experience in these institutions has allowed him to develop and refine his innovative approaches to medical treatment.
Collaborations
Zimran has collaborated with notable colleagues, including Yaron Ilan and Maya Margalit, who have contributed to his research and development efforts.
Conclusion
Ari Zimran's contributions to medical innovation highlight his commitment to improving treatment options for various diseases. His patents reflect a deep understanding of complex medical challenges and a dedication to finding effective solutions.